Karyopharm Therapeutics (KPTI) Stock Highlights

0.99 | -5.71%

2024-05-29 03:58:11

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. Karyopharms lead compound, XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma.

Statistics

Range Today

0.98 1.07

Volume Today 1.45M

Range 1 Year

0.62 2.47

Volume 1 Year 450.23M

Range 3 Year

0.62 14.73

Volume 3 Year 1.63B

Range 10 Year

0.62 49.005

Volume 10 Year 3.16B

Highlights

Market Capitalization 123.6M (small)

Floating Shares 107.82M

Current Price 0.99

Price To Earnings -0.86

Price To Revenue 2.02

Earnings Per Share -1.27

Payout Ratio 0%

Performance

Latest -5.71%

1 Month -6.6%

3 Months -29.79%

6 Months +33.78%

1 Year -57.33%

3 Years -89.41%

5 Years -84.19%

10 Years -96.39%

Benchmarks

Market Capitalization

238 / 368

Gross Profits

39 / 278

Total Revenue

75 / 300

Total Rank

173 / 368

Free Cashflow

198 / 352

Performance 5 years

267 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.